Journal Watch · Journal of Medicinal Chemistry · 2026

Structure-Guided Grafting of Cell-Penetrating Motifs into Stapled Peptides for Intracellular PPI Inhibition.

This approach provides a structure-guided platform for intracellular PPI-targeting peptides.

Fujita M, Konuma T, Yoshida A et al.Journal of Medicinal Chemistry3 min readPharma relevance 60/100

DOI: 10.1021/acs.jmedchem.6c00663PMID: 42212626Study type: research study

TL;DR

This approach provides a structure-guided platform for intracellular PPI-targeting peptides.

Key findings

  • The strategy was also validated in the β-catenin/TCF system, where CPP-grafted peptides retained binding affinity, suppressed Wnt signaling, and inhibited cancer cell proliferation.
  • This approach provides a structure-guided platform for intracellular PPI-targeting peptides.

What they did

Based on computational identification of hotspot residues, CPP motifs were embedded into regions dispensable for binding. Applied to the MDM2/p53 interaction, the CPP-grafted stapled peptide <b>St3-R</b> showed enhanced cellular uptake and improved intracellular inhibitory activity compared with CPP-conjugated analogues. X-ray crystallography confirmed the preservation of key hydrophobic hotspot residues after grafting.

Full abstract (original)

Background: Protein-protein interactions (PPIs) are promising drug targets, yet peptide modulation of intracellular PPIs is limited by poor membrane permeability. Although conjugation with cell-penetrating peptides (CPPs) improves delivery, it often increases molecular weight, induces nonspecific interactions, and compromises target binding. Here, we present a CPP grafting strategy that integrates membrane permeability into peptide design while preserving binding capability.

What they did: Based on computational identification of hotspot residues, CPP motifs were embedded into regions dispensable for binding. Applied to the MDM2/p53 interaction, the CPP-grafted stapled peptide <b>St3-R</b> showed enhanced cellular uptake and improved intracellular inhibitory activity compared with CPP-conjugated analogues. X-ray crystallography confirmed the preservation of key hydrophobic hotspot residues after grafting.

Results & conclusions: The strategy was also validated in the β-catenin/TCF system, where CPP-grafted peptides retained binding affinity, suppressed Wnt signaling, and inhibited cancer cell proliferation. This approach provides a structure-guided platform for intracellular PPI-targeting peptides.

Abstract © the authors / Journal of Medicinal Chemistry (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1021/acs.jmedchem.6c00663 · PubMed 42212626.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Journal of Medicinal Chemistry study find?

This approach provides a structure-guided platform for intracellular PPI-targeting peptides.

What type of study is this?

It is a research study, published in Journal of Medicinal Chemistry in 2026. Based on computational identification of hotspot residues, CPP motifs were embedded into regions dispensable for binding.

Where can I read the original paper?

The original is at the publisher via DOI 10.1021/acs.jmedchem.6c00663. PubMed ID: 42212626. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Fujita M, Konuma T, Yoshida A et al.. Structure-Guided Grafting of Cell-Penetrating Motifs into Stapled Peptides for Intracellular PPI Inhibition.. Journal of Medicinal Chemistry (2026). DOI: 10.1021/acs.jmedchem.6c00663.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/structure-guided-grafting-of-cell-penetrating-motifs-into-stapled-peptid-c00663/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides